Your browser doesn't support javascript.
loading
Efficacy and Mechanism of the Jiangtang Tiaozhi Recipe in the Management of Type 2 Diabetes and Dyslipidaemia: A Clinical Trial Protocol.
Wu, Haoran; Fang, Xinyi; Jin, De; Miao, Runyu; Wei, Jiahua; Zhao, Tianyu; Dai, Dan; Liao, Jiangquan; Wang, Jia; Lian, Fengmei; Tian, Jiaxing.
Afiliación
  • Wu H; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Fang X; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
  • Jin; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Miao R; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
  • Wei J; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhao T; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Dai D; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
  • Liao J; Graduate College, Changchun University of Chinese Medicine, Changchun, China.
  • Wang J; Department of Endocrinology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Lian F; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Tian J; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
Front Pharmacol ; 13: 827697, 2022.
Article en En | MEDLINE | ID: mdl-35185579

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China